Logo image of WST

WEST PHARMACEUTICAL SERVICES (WST) Stock Price, Quote, News and Overview

NYSE:WST - New York Stock Exchange, Inc. - US9553061055 - Common Stock - Currency: USD

212.48  -2.95 (-1.37%)

WST Quote, Performance and Key Statistics

WEST PHARMACEUTICAL SERVICES

NYSE:WST (5/21/2025, 11:46:51 AM)

212.48

-2.95 (-1.37%)

Sector
GICS SectorHealth Care
GICS IndustryLife Sciences Tools & Services
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryLife Sciences Tools & Services
Statistics
52 Week High352.33
52 Week Low187.43
Market Cap15.27B
Shares71.85M
Float71.42M
Yearly Dividend0.81
Dividend Yield0.4%
PE32
Fwd PE29.48
Earnings (Next)07-23 2025-07-23/bmo
IPO07-27 1923-07-27


WST short term performance overview.The bars show the price performance of WST in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -10 -20 -30

WST long term performance overview.The bars show the price performance of WST in the last 1, 2 and 3 years. 1 year 2 years 3 years -10 -20 -30

The current stock price of WST is 212.48 USD. In the past month the price increased by 0.14%. In the past year, price decreased by -35.04%.

WEST PHARMACEUTICAL SERVICES / WST Daily stock chart

WST Competitors/Peers

The largest stocks on the US markets in the "Life Sciences Tools & Services" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
TMO THERMO FISHER SCIENTIFIC INC 18.54 153.23B
DHR DANAHER CORP 25.66 136.79B
A AGILENT TECHNOLOGIES INC 20.82 31.53B
IQV IQVIA HOLDINGS INC 12.39 24.68B
MTD METTLER-TOLEDO INTERNATIONAL 28.73 24.23B
WAT WATERS CORP 29.62 20.99B
ILMN ILLUMINA INC 24.44 12.88B
RVTY REVVITY INC 18.64 11.04B
TEM TEMPUS AI INC N/A 10.82B
ICLR ICON PLC 9.37 10.61B
QGEN QIAGEN N.V. 18.66 9.27B
AVTR AVANTOR INC 12.73 8.76B

About WST

Company Profile

WST logo image West Pharmaceutical Services, Inc. engages in the manufacture and marketing of pharmaceuticals, biologics, vaccines, and consumer healthcare products. The company is headquartered in Exton, Pennsylvania and currently employs 10,600 full-time employees. The firm operates in two segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers elastomers & primary containment, drug delivery devices, integrated solutions, and analytical lab services, primarily to biologic, generic, and pharmaceutical drug customers. The Contract-Manufactured Products reportable segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. This segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.

Company Info

WEST PHARMACEUTICAL SERVICES

530 Herman O. West Drive

Exton PENNSYLVANIA 19341 US

CEO: Eric M. Green

Employees: 10600

WST Company Website

WST Investor Relations

Phone: 16105942900

WEST PHARMACEUTICAL SERVICES / WST FAQ

What is the stock price of WEST PHARMACEUTICAL SERVICES today?

The current stock price of WST is 212.48 USD. The price decreased by -1.37% in the last trading session.


What is the ticker symbol for WEST PHARMACEUTICAL SERVICES stock?

The exchange symbol of WEST PHARMACEUTICAL SERVICES is WST and it is listed on the New York Stock Exchange, Inc. exchange.


On which exchange is WST stock listed?

WST stock is listed on the New York Stock Exchange, Inc. exchange.


What is the price forecast or stock price prediction for WEST PHARMACEUTICAL SERVICES stock?

18 analysts have analysed WST and the average price target is 283.11 USD. This implies a price increase of 33.24% is expected in the next year compared to the current price of 212.48. Check the WEST PHARMACEUTICAL SERVICES stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is WEST PHARMACEUTICAL SERVICES worth?

WEST PHARMACEUTICAL SERVICES (WST) has a market capitalization of 15.27B USD. This makes WST a Large Cap stock.


How many employees does WEST PHARMACEUTICAL SERVICES have?

WEST PHARMACEUTICAL SERVICES (WST) currently has 10600 employees.


What are the support and resistance levels for WEST PHARMACEUTICAL SERVICES (WST) stock?

WEST PHARMACEUTICAL SERVICES (WST) has a support level at 209.3 and a resistance level at 216.26. Check the full technical report for a detailed analysis of WST support and resistance levels.


Is WEST PHARMACEUTICAL SERVICES (WST) expected to grow?

The Revenue of WEST PHARMACEUTICAL SERVICES (WST) is expected to grow by 2.68% in the next year. Check the estimates tab for more information on the WST EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy WEST PHARMACEUTICAL SERVICES (WST) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does WEST PHARMACEUTICAL SERVICES (WST) stock pay dividends?

WEST PHARMACEUTICAL SERVICES (WST) has a dividend yield of 0.4%. The yearly dividend amount is currently 0.81. Check the full fundamental report for a detailed analysis of WST dividend history, reliability and sustainability.


When does WEST PHARMACEUTICAL SERVICES (WST) report earnings?

WEST PHARMACEUTICAL SERVICES (WST) will report earnings on 2025-07-23, before the market open.


What is the Price/Earnings (PE) ratio of WEST PHARMACEUTICAL SERVICES (WST)?

The PE ratio for WEST PHARMACEUTICAL SERVICES (WST) is 32. This is based on the reported non-GAAP earnings per share of 6.64 and the current share price of 212.48 USD. Check the full fundamental report for a full analysis of the valuation metrics for WST.


What is the Short Interest ratio of WEST PHARMACEUTICAL SERVICES (WST) stock?

The outstanding short interest for WEST PHARMACEUTICAL SERVICES (WST) is 3.53% of its float. Check the ownership tab for more information on the WST short interest.


WST Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to WST. When comparing the yearly performance of all stocks, WST is a bad performer in the overall market: 78.71% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

WST Fundamental Analysis

ChartMill assigns a fundamental rating of 6 / 10 to WST. Both the health and profitability get an excellent rating, making WST a very profitable company, without any liquidiy or solvency issues.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

WST Financial Highlights

Over the last trailing twelve months WST reported a non-GAAP Earnings per Share(EPS) of 6.64. The EPS decreased by -13.32% compared to the year before.


Industry RankSector Rank
PM (TTM) 16.13%
ROA 12.91%
ROE 17.41%
Debt/Equity 0.08
Chartmill High Growth Momentum
EPS Q2Q%-7.05%
Sales Q2Q%0.37%
EPS 1Y (TTM)-13.32%
Revenue 1Y (TTM)-1.12%

WST Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 81% to WST. The Buy consensus is the average rating of analysts ratings from 18 analysts.

For the next year, analysts expect an EPS growth of -5.81% and a revenue growth 2.68% for WST


Ownership
Inst Owners97.06%
Ins Owners0.34%
Short Float %3.53%
Short Ratio2.59
Analysts
Analysts81.11
Price Target283.11 (33.24%)
EPS Next Y-5.81%
Revenue Next Year2.68%